(Q45703576)

15 December 2017

title

Safety and antigenicity of whole virus and subunit influenza A/Hong Kong/1073/99 (H9N2) vaccine in healthy adults: phase I randomised trial (English)

1 reference

15 December 2017

main subject

phase I clinical trial

0 references

author name string

Iain Stephenson

1

1 reference

15 December 2017

Karl G Nicholson

2

1 reference

15 December 2017

Reinhardt Glück

3

1 reference

15 December 2017

Robert Mischler

4

1 reference

15 December 2017

Robert W Newman

5

1 reference

15 December 2017

Abraham M Palache

6

1 reference

15 December 2017

Neville Q Verlander

7

1 reference

15 December 2017

Fiona Warburton

8

1 reference

15 December 2017

John M Wood

9

1 reference

15 December 2017

Maria C Zambon

10

1 reference

15 December 2017

language of work or name

English

0 references

publication date

1 December 2003

1 reference

15 December 2017

1 reference

15 December 2017

volume

362

1 reference

15 December 2017

issue

9400

1 reference

15 December 2017

page(s)

1959-1966

1 reference

Human infection with influenza H9N2.

15 December 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Characterization of a human H9N2 influenza virus isolated in Hong Kong

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Molecular characterization of H9N2 influenza viruses: were they the donors of the "internal" genes of H5N1 viruses in Hong Kong?

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Avian-to-human transmission of H9N2 subtype influenza A viruses: relationship between H9N2 and H5N1 human isolates.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Human influenza A H5N1 virus related to a highly pathogenic avian influenza virus

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Safety and antigenicity of non-adjuvanted and MF59-adjuvanted influenza A/Duck/Singapore/97 (H5N3) vaccine: a randomised trial of two potential vaccines against H5N1 influenza.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Boosting immunity to influenza H5N1 with MF59-adjuvanted H5N3 A/Duck/Singapore/97 vaccine in a primed human population

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Sialic acid receptor specificity on erythrocytes affects detection of antibody to avian influenza haemagglutinin.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Clinical studies of monovalent inactivated whole virus and subunit A/USSR/77 (H1N1) vaccine: serological responses and clinical reactions

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Molecular analysis of an outbreak of influenza in the United Kingdom

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Detection of antibody to avian influenza A (H5N1) virus in human serum by using a combination of serologic assays.

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

H5 avian and H9 swine influenza virus haemagglutinin structures: possible origin of influenza subtypes

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

Pandemic preparedness: lessons learnt from H2N2 and H9N2 candidate vaccines

1 reference

https://api.crossref.org/works/10.1016%2FS0140-6736%2803%2915014-3

7 January 2021

10.1016/S0140-6736(03)15014-3

Identifiers

DOI

1 reference

15 December 2017

1 reference